TLSB-16 GENOMIC AND CLINICAL PREDICTORS OF SURVIVAL FOLLOWING SURGICAL RESECTION OF BRAIN METASTASES
ECOG performance status, KRAS copy number alterations, and postoperative systemic therapy are independently associated with survival following brain metastasis resection, and integrating molecular profiling with clinical factors provides a framework for postoperative survival risk stratification.